• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Right Arrow Button IconLeft Arrow Button IconHome
Right Arrow Button IconWeight Loss

Weight Loss

Page 5 of 6
HealthHow Richard Simmons, a former overweight teen, became a celebrity weight loss coach and workout icon
By Mark Kennedy and The Associated PressJuly 14, 2024
A bathroom scale is surrounded by colorful pills.
HealthPharma giant Pfizer is trying to cash in on the weight loss drug craze with a new pill that could be a welcome needle-free alternative to pesky GLP-1 shots
By Damian Garde and BloombergJuly 11, 2024
A person using Ozempic on November 2, 2023, in Madrid, Spain. Novo Nordisk, the Danish firm that manufactures Ozempic, has reported record quarterly results, up almost 3% on the stock market. The company's revenues rose by 38% to DKK 58.73 billion, some 7.8 billion euros. Ozempic is a diabetic drug that causes a loss of up to 15% of body weight because it acts as an appetite suppressant, a side effect that has made the drug fashionable on social media as a weight loss drug.
FeaturesOzempic and Wegovy are marketed as a short-term holy grail for weight loss by some startups. Doctors disagree
By Jessica Mathews and Alena BotrosJuly 9, 2024
Close-up of an Ozempic pen in a greenwash style
HealthOzempic linked to rare cases of vision loss in Harvard study
By Robert Langreth and BloombergJuly 3, 2024
HealthFake Ozempic and Wegovy are flooding the market. Here are 4 steps to avoid dangerous counterfeit weight loss drugs
By Amanda LoudinJune 27, 2024
HealthEU urges clampdown on cosmetic misuse of Novo’s Ozempic amid worsening drug shortages for diabetics
By Naomi Kresge and BloombergJune 26, 2024
Lars Fruergaard Jorgensen, CEO of Novo Nordisk.
HealthNovo Nordisk plots $4.1 billion in U.S. factory amid Ozempic shortage, the same day it pulled out of its Ireland development project
By Naomi Kresge and BloombergJune 25, 2024
RetailBaggy pants are out and smaller sizes are flying off the shelves as Wegovy changes how Americans buy clothes
By Marco Quiroz-GutierrezJune 17, 2024
Lars Fruergaard Jorgensen, chief executive officer of Novo Nordisk A/S, gestures while speaking during a Bloomberg Television interview in London, U.K.
RetailOzempic is 1,300% more expensive in the U.S. vs the U.K.—so the boss of Novo Nordisk is being hauled in front of Bernie Sanders to explain why
By Ryan HoggJune 17, 2024
HealthOzempic and Wegovy are so hard to find that a startup invented a free tool for tracking whether the viral drugs are in stock
By Marco Quiroz-GutierrezMay 29, 2024
Dr. Razia Hashmi, vice president of clinical affairs, Blue Cross Blue Shield Association, speaks during Fortune’s Brainstorm Health conference in Dana Point, Calif., on Tuesday, May 21, 2024.
HealthGLP-1 drugs like Wegovy are all the rage—but people are quitting them too fast to achieve meaningful weight loss, finds 170,000-patient study
By Lindsey LeakeMay 22, 2024
Dr. Patrick Carroll (right), Hims & Hers chief medical officer, speaks during Fortune’s Brainstorm Health conference in Dana Point, Calif., Monday, May 20, 2024.
ConferencesHims & Hers’ surprise 85% Wegovy discount is latest step on a journey to make medicine less ‘paternalistic,’ exec says
By Marco Quiroz-GutierrezMay 20, 2024
People living with obesity reap the greatest health benefits from being physically active in the evening, according to a new Australian study.
LifeThis is the best time of day to exercise for people living with obesity, new study shows
By Lindsey LeakeMay 17, 2024
NewslettersEmployees are secretly bringing their own AI tools to work so they can keep up
By Sheryl EstradaMay 10, 2024
Insulin injection pen
NewslettersHow the CFOs of Eli Lilly and Novo Nordisk are coping with ‘unprecedented demand’ for weight-loss drugs
By Sheryl EstradaMay 3, 2024
1
  • 2
  • 3
  • 4
  • 5
  • 6
6
Most Popular
Law
DOGE cancelled a $349,000 grant to replace a museum’s HVAC after ChatGPT flagged it as DEI, court documents showAn image of a popular article
By Fortune EditorsMarch 19, 2026
Economy
Social Security has 6 years left. The fix that sounds cruelest may be the smartestAn image of a popular article
By Fortune EditorsMarch 19, 2026
Economy
Jerome Powell says you're right to blame data centers for making your bills more expensive: 'probably pushing inflation up'An image of a popular article
By Fortune EditorsMarch 19, 2026
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • Future 50
  • World’s Most Admired Companies
  • See All Rankings
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • Pinterest icon

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.